Adial Pharmaceuticals, Inc.

8-K Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Unregistered sale of equity; Director or officer change; Amended charter or bylaws; Regulation FD disclosure Jun 11, 2026 8-K Results of operations (earnings release) May 11, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 8-K Director or officer change Apr 9, 2026 8-K Results of operations (earnings release) Mar 6, 2026 10-K Fiscal year ended 2025-12-31 Mar 5, 2026 8-K Regulation FD disclosure; Other events Mar 3, 2026 8-K Other events Feb 24, 2026 8-K Modified rights of security holders; Amended charter or bylaws; Other events Feb 4, 2026 8-K Director or officer change Jan 6, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events Dec 1, 2025 8-K Results of operations (earnings release) Nov 14, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Regulation FD disclosure; Other events Sep 16, 2025 8-K Delisting notice or listing-rule failure Sep 3, 2025 8-K Results of operations (earnings release) Aug 14, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Entered a material agreement; Terminated a material agreement Aug 1, 2025 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Aug 1, 2025 8-K Other events Jul 16, 2025 8-K Other events Jul 10, 2025 8-K Entered a material agreement; Other events Jun 18, 2025 8-K Item 5.08; Other events Jun 16, 2025 8-K Delisting notice or listing-rule failure May 30, 2025 8-K Item 5.08; Other events May 15, 2025 8-K Results of operations (earnings release) May 15, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events May 7, 2025 8-K Changed accountants May 1, 2025 8-K Director or officer change Mar 21, 2025 8-K Delisting notice or listing-rule failure Mar 7, 2025 8-K Results of operations (earnings release) Mar 4, 2025 10-K Fiscal year ended 2024-12-31 Mar 4, 2025 8-K Regulation FD disclosure; Other events Feb 25, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Regulation FD disclosure Jan 8, 2025 8-K Entered a material agreement; Terminated a material agreement; Unregistered sale of equity Dec 18, 2024 8-K Director or officer change Dec 6, 2024 8-K Regulation FD disclosure; Other events Nov 18, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024